GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 166 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2020. The put-call ratio across all filers is 3.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $31,000 | -89.9% | 1,288 | -93.9% | 0.00% | -100.0% |
| Q4 2020 | $307,000 | +14.6% | 21,008 | +15.1% | 0.00% | 0.0% |
| Q2 2020 | $268,000 | +6600.0% | 18,249 | +5983.0% | 0.00% | – |
| Q4 2016 | $4,000 | -89.7% | 300 | -93.9% | 0.00% | -100.0% |
| Q3 2015 | $39,000 | +457.1% | 4,900 | +521.8% | 0.00% | – |
| Q2 2015 | $7,000 | -74.1% | 788 | -65.0% | 0.00% | -100.0% |
| Q3 2013 | $27,000 | -22.9% | 2,250 | -32.8% | 0.00% | 0.0% |
| Q2 2013 | $35,000 | – | 3,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|